|
 |
|
|||||||
|
|||||||||
Diabetes 51:1793-1804, 2002
© 2002 by the American Diabetes Association, Inc.
Overexpression of c-Myc in ß-Cells of Transgenic Mice Causes Proliferation and Apoptosis, Downregulation of Insulin Gene Expression, and Diabetes
1 Section of Islet Transplantation and Cell Biology, Joslin Diabetes Center, Boston, Massachusetts
2 Howard Hughes Medical Institute, University of Washington, Seattle, Washington
To test the hypothesis that c-Myc plays an important role in ß-cell growth and differentiation, we generated transgenic mice overexpressing c-Myc in ß-cells under control of the rat insulin II promoter. F1 transgenic mice from two founders developed neonatal diabetes (associated with reduced plasma insulin levels) and died of hyperglycemia 3 days after birth. In pancreata of transgenic mice, marked hyperplasia of cells with an altered phenotype and amorphous islet organization was displayed: islet volume was increased threefold versus wild-type littermates. Apoptotic nuclei were increased fourfold in transgenic versus wild-type mice, suggesting an increased turnover of ß-cells. Very few cells immunostained for insulin; pancreatic insulin mRNA and content were markedly reduced. GLUT2 mRNA was decreased, but other ß-cell–associated genes (IAPP [islet amyloid pancreatic polypeptide], PDX-1 [pancreatic and duodenal homeobox-1], and BETA2/NeuroD) were expressed at near-normal levels. Immunostaining for both GLUT2 and Nkx6.1 was mainly cytoplasmic. The defect in ß-cell phenotype in transgenic embryos (embryonic days 17–18) and neonates (days 1–2) was similar and, therefore, was not secondary to overt hyperglycemia. When pancreata were transplanted under the kidney capsules of athymic mice to analyze the long-term effects of c-Myc activation, ß-cell depletion was found, suggesting that, ultimately, apoptosis predominates over proliferation. In conclusion, these studies demonstrate that activation of c-Myc in ß-cells leads to 1) increased proliferation and apoptosis, 2) initial hyperplasia with amorphous islet organization, and 3) selective downregulation of insulin gene expression and the development of overt diabetes.
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  D. A. Cano, I. C. Rulifson, P. W. Heiser, L. B. Swigart, S. Pelengaris, M. German, G. I. Evan, J. A. Bluestone, and M. Hebrok Regulated {beta}-Cell Regeneration in the Adult Mouse Pancreas Diabetes, April 1, 2008; 57(4): 958 - 966. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Matsumura, B. H.-J. Chang, M. Fujimiya, W. Chen, R. N. Kulkarni, Y. Eguchi, H. Kimura, H. Kojima, and L. Chan Aquaporin 7 Is a {beta}-Cell Protein and Regulator of Intraislet Glycerol Content and Glycerol Kinase Activity, {beta}-Cell Mass, and Insulin Production and Secretion Mol. Cell. Biol., September 1, 2007; 27(17): 6026 - 6037. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. C. Kaizer, C. L. Glaser, D. Chaussabel, J. Banchereau, V. Pascual, and P. C. White Gene Expression in Peripheral Blood Mononuclear Cells from Children with Diabetes J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3705 - 3711. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Chen, H.-X. Yan, J. Chen, W. Yang, Q. Liu, B. Zhai, H.-F. Cao, S.-Q. Liu, M.-C. Wu, and H.-Y. Wang Negative Regulation of c-Myc Transcription by Pancreas Duodenum Homeobox-1 Endocrinology, May 1, 2007; 148(5): 2168 - 2180. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Ronn, N. Billestrup, and T. Mandrup-Poulsen Diabetes and Suppressors of Cytokine Signaling Proteins Diabetes, February 1, 2007; 56(2): 541 - 548. [Full Text] [PDF]
|
|
|
|
 |
|
 I. Cozar-Castellano, N. Fiaschi-Taesch, T. A. Bigatel, K. K. Takane, A. Garcia-Ocana, R. Vasavada, and A. F. Stewart Molecular Control of Cell Cycle Progression in the Pancreatic {beta}-Cell Endocr. Rev., June 1, 2006; 27(4): 356 - 370. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. Lawlor, L. Soucek, L. Brown-Swigart, K. Shchors, C. U. Bialucha, and G. I. Evan Reversible Kinetic Analysis of Myc Targets In vivo Provides Novel Insights into Myc-Mediated Tumorigenesis. Cancer Res., May 1, 2006; 66(9): 4591 - 4601. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H Del Zotto, M I Borelli, L Flores, M E Garcia, C L Gomez Dumm, A Chicco, Y B Lombardo, and J J Gagliardino Islet neogenesis: an apparent key component of long-term pancreas adaptation to increased insulin demand J. Endocrinol., November 1, 2004; 183(2): 321 - 330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Yang, U. Fransson, L. Fagerhus, L. Stenson Holst, H. E. Hohmeier, E. Renstrom, and H. Mulder Enhanced cAMP Protein Kinase A Signaling Determines Improved Insulin Secretion in a Clonal Insulin-Producing {beta}-Cell Line (INS-1 832/13) Mol. Endocrinol., September 1, 2004; 18(9): 2312 - 2320. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. da Silva Xavier, J. Rutter, and G. A. Rutter Involvement of Per-Arnt-Sim (PAS) kinase in the stimulation of preproinsulin and pancreatic duodenum homeobox 1 gene expression by glucose PNAS, June 1, 2004; 101(22): 8319 - 8324. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Laybutt, M. Glandt, G. Xu, Y. B. Ahn, N. Trivedi, S. Bonner-Weir, and G. C. Weir Critical Reduction in beta -Cell Mass Results in Two Distinct Outcomes over Time. ADAPTATION WITH IMPAIRED GLUCOSE TOLERANCE OR DECOMPENSATED DIABETES J. Biol. Chem., January 24, 2003; 278(5): 2997 - 3005. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |